Silencing TRIP13 inhibits cell growth and metastasis of hepatocellular carcinoma by activating of TGF-β1/smad3

BACKGROUND: TRIP13 is highly expressed in several cancers and is closely connected with cancer progression. However, its roles on the growth and metastasis of hepatocellular carcinoma (HCC), and the underlying mechanism are still unclear. METHODS: Combining bioinformatics with previous studies, the...

Descripción completa

Detalles Bibliográficos
Autores principales: Yao, Jianning, Zhang, Xuexiu, Li, Jiaheng, Zhao, Dongyao, Gao, Bing, Zhou, Haining, Gao, Shilin, Zhang, Lianfeng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296061/
https://www.ncbi.nlm.nih.gov/pubmed/30564064
http://dx.doi.org/10.1186/s12935-018-0704-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6296061/
https://www.ncbi.nlm.nih.gov/pubmed/30564064
http://dx.doi.org/10.1186/s12935-018-0704-y

Ejemplares similares